FDA Inspection 1027273 — Hemolife Medical Inc
The FDA completed an inspection of Hemolife Medical Inc on August 18, 2017 in Dana Point, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 18, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Dana Point, CA (United States)